| CEO: | Phil L'Huillier |
| CFO: | Sath Nirmalananthan |
| Chief Scientific Officer: | Lindy Durrant |
| Deputy Chairman: | Susan Clement Davies |
| Non-Executive Chairman: | Jean-Michel Cosséry |
| Non-Executive Dir: | Martin Diggle , Ursula Ney, Florian Reinaud |
| Address: | Bellhouse Building, Sanders Road, Oxford Science Park, Oxford, United Kingdom , OX4 4GD |
| Website: | http://www.scancell.co.uk/ |
| Sector: | Pharma and Biotech(LSE) |
| Index: | FTSE AIM All-Share |
| ISIN: | GB00B63D3314 |
| Currency | UK Pounds |
| Share Price | 9.60p |
| Change Today | -0.100p |
| % Change | -1.03 % |
| 52 Week High | 26.25 |
| 52 Week Low | 9.20 |
| Volume | 1,991,380 |
| Shares Issued | 1,212.23m |
| Market Cap | £116.37m |
| Value | ![]() |
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth | ![]() |
|---|
| Strong Buy | 1 |
| Buy | 1 |
| Neutral | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 2 |

| No dividends found |
| Time | Volume / Share Price |
| 16:08 | 10,000 @ 9.63p |
| 15:38 | 10,311 @ 9.64p |
| 15:17 | 20,000 @ 9.53p |
| 15:16 | 200,000 @ 9.53p |
| 15:14 | 426 @ 9.60p |
| CFO | Sath Nirmalananthan |
| CEO | Phil L'Huillier |
You are here: research